MSB 6.07% $1.01 mesoblast limited

ODAC August 2020 event materials, page-40

  1. 16,705 Posts.
    lightbulb Created with Sketch. 2386
    In 2013 Mesoblast acquired Prochymal for $50m. The company hasn't really added any value to that, although it's spent a huge amount on failed trials, and is in hock for $90m with the IP pledged as security. So to me a market cap of $1B looks like a Ponzi scheme on steroids, if such a thing is possible.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.